We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study

    Purpose

    Data on the prognostic impact of the micropapillary component in breast cancer are limited. The purpose of this study was to investigate the...

    Francesca Magnoni, Beatrice Bianchi, ... Paolo Veronesi in Breast Cancer Research and Treatment
    Article 04 July 2024
  2. Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ

    Purpose

    The purpose of this study is to compare and analyze the clinicopathological characteristics and prognosis of patients with invasive ductal...

    Article Open access 24 June 2023
  3. Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance

    Ductal carcinoma in situ (DCIS) represents pre-invasive breast carcinoma. In untreated cases, 25–60% DCIS progress to invasive ductal carcinoma...

    **g Wang, Baizhou Li, ... Jiaojiao Zhou in Signal Transduction and Targeted Therapy
    Article Open access 03 April 2024
  4. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report

    Background

    Although lung and breast cancers are common malignancies, the occurrence of primary synchronous neoplasms involving these organs has been...

    Junqing Gan, Meiyue Liu, ... **ghao Jia in BMC Pulmonary Medicine
    Article Open access 22 February 2024
  5. Prognostic Implications of Concurrent Ductal Carcinoma In Situ in Invasive Breast Cancer: an Observational Nested Cohort Study from a Regional Cancer Center in India

    Ductal Carcinoma In Situ (DCIS) is not an obligate precursor to invasive breast cancer and can exhibit variations in clinical presentation, genetics,...

    Shanthala S, Usha Amirtham, ... Linu Jacob in Indian Journal of Surgical Oncology
    Article 04 December 2023
  6. Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer

    Purpose

    The progression of ductal carcinoma in situ (DCIS) to invasive breast carcinoma (IBC) in humans is highly variable. To better understand the...

    Henry G. Kaplan, Alexa K. Dowdell, ... Brian D. Piening in Breast Cancer Research and Treatment
    Article Open access 24 March 2024
  7. Digital mammography and digital breast tomosynthesis for detecting invasive lobular and ductal carcinoma

    Purpose

    Invasive lobular carcinoma (ILC) is a distinct histological subtype of breast cancer that can make early detection with mammography...

    Tracy Onega, Linn Abraham, ... Roberta M. di Florio-Alexander in Breast Cancer Research and Treatment
    Article 11 September 2023
  8. Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study

    Background

    Retrospective observational studies suggest a potential role of beta-blockers as a protective strategy against progression and metastasis...

    Carina Strell, Daniel Robert Smith, ... Aglaia Schiza in Breast Cancer Research and Treatment
    Article Open access 19 May 2024
  9. Alcohol consumption, smoking, and invasive breast cancer risk after ductal carcinoma in situ

    Purpose

    Alcohol is an established risk factor for invasive breast cancer, and women with a prior ductal carcinoma in situ diagnosis are at higher risk...

    Kristina M. Jordahl, Kathleen E. Malone, ... Christopher I. Li in Breast Cancer Research and Treatment
    Article 27 March 2022
  10. Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis

    Background

    Metaplastic breast cancer(MBC) is a specific pathological type of invasive breast cancer. There are few studies related to MBC due to its...

    **aolu Yang, Tiantian Tang, Tao Zhou in World Journal of Surgical Oncology
    Article Open access 24 November 2023
  11. Germline Genetic Testing Among Women ≤ 45 Years of Age with Ductal Carcinoma In Situ Versus Invasive Breast Cancer in a Large Integrated Health Care System

    Background

    We compared the results of hereditary cancer multigene panel testing among patients ≤ 45 years of age diagnosed with ductal carcinoma in...

    Diana S. Hsu, Sheng-Fang Jiang, ... Veronica C. Shim in Annals of Surgical Oncology
    Article 29 June 2023
  12. STK3 higher expression association with clinical characteristics in intrinsic subtypes of breast cancer invasive ductal carcinoma patients

    Purpose

    STK3 has a central role in maintaining cell homeostasis, proliferation, growth, and apoptosis. Previously, we investigated the functional link...

    Rukhsana, Afia Tasnim Supty, ... YoungJoo Lee in Breast Cancer Research and Treatment
    Article 09 April 2024
  13. The VISTA/VSIG3/PSGL-1 axis: crosstalk between immune effector cells and cancer cells in invasive ductal breast carcinoma

    A checkpoint protein called the V-domain Ig suppressor of T cell activation (VISTA) is important for controlling immune responses. Immune cells that...

    Mateusz Olbromski, Monika Mrozowska, ... Hanna Romanowicz in Cancer Immunology, Immunotherapy
    Article Open access 04 June 2024
  14. SGLT1 as an adverse prognostic factor in invasive ductal carcinoma of the breast

    Purpose

    Sodium/glucose cotransporter (SGLT) 1 and 2 expression in carcinoma cells was recently examined, but their association with the...

    Satoko Tsunokake, Erina Iwabuchi, ... Takashi Suzuki in Breast Cancer Research and Treatment
    Article 13 July 2023
  15. Expression of Immune Checkpoint Regulator Cytotoxic T Lymphocyte Antigen 4 (CTLA-4) and Programmed Cell Death Protein Ligand 1 (PD-L1) in Invasive Ductal Carcinoma Breast

    Despite significant advancement in the diagnostic and therapeutic aspects of breast carcinoma, the prognosis remains dismal. Recently, with advances...

    Preeti Diwaker, Tanvi Jha, ... Navneet Kaur in Indian Journal of Surgical Oncology
    Article 13 June 2024
  16. Axillary lymph node status and invasive lobular breast cancer

    Background

    Invasive lobular carcinoma (ILC) represents the second most common type of invasive breast cancer (BC). Although ILC generally have good...

    Sabine Danzinger, Karin Pöckl, ... Christian F. Singer in Wiener klinische Wochenschrift
    Article Open access 03 April 2023
  17. Novel associations between MTDH gene polymorphisms and invasive ductal breast cancer: a case–control study

    Objective

    To reveal the contributing effects of MTDH gene SNPs in the risk of invasive ductal breast cancer (IDC).

    Patients and methods ...
    Yan Huang, Dan Dai, ... **anzhong Qi in Discover Oncology
    Article Open access 09 July 2024
  18. Acute annular outer retinopathy preceded by invasive ductal breast carcinoma: a case report

    Background

    Acute annular outer retinopathy (AAOR) is an uncommon disease. To date, there are few documented cases in the literature. Our case report...

    Rishi B. Gupta, Harry Dang, ... Chloe C. Gottlieb in BMC Ophthalmology
    Article Open access 24 November 2022
  19. Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis

    Purpose

    Ductal carcinoma in situ (DCIS) is present in more than half of HER2-positive invasive breast cancer (IBC). Recent studies show that DCIS...

    Roxanne A. W. Ploumen, Eva L. Claassens, ... Marjolein L. Smidt in Breast Cancer Research and Treatment
    Article Open access 03 July 2023
Did you find what you were looking for? Share feedback.